919 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Stocks making the biggest moves midday: Mattel, CrowdStrike, Dave & Buster's https://www.cnbc.com/2019/06/12/stocks-making-the-biggest-moves-midday-mattel-crowdstrike-dave-busters.html Jun 12, 2019 - Names on the move ahead of the open.
Teva hits 19-year low on continued pricing pressure https://seekingalpha.com/news/3470793-teva-hits-19-year-low-continued-pricing-pressure?source=feed_news_all Jun 12, 2019 - Teva Pharmaceutical Industries (TEVA -4.2%) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the cont
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/426494/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-426494 Jun 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.26 in the latest trading session, marking a -1.59% move from the prior day.
Celgene's Filing for Ozanimod Accepted for Review in US/EU http://www.zacks.com/stock/news/426482/celgenes-filing-for-ozanimod-accepted-for-review-in-us-eu?cid=CS-ZC-FT-426482 Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Lilly's Emgality Gets FDA Approval for Cluster Headache http://www.zacks.com/stock/news/425463/lillys-emgality-gets-fda-approval-for-cluster-headache?cid=CS-ZC-FT-425463 Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Here are the biggest analyst calls of the day: Alphabet, Big Lots, Salesforce & more https://www.cnbc.com/2019/06/03/calls-of-the-day-alphabet-big-lots-salesforce-more.html Jun 03, 2019 - Here are the biggest calls on Wall Street on Monday
TEVA: Oppenheimer ups to Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20190603072527 Jun 03, 2019 - Oppenheimer issues rating change for TEVA
Biogen Reports Interim Phase III Data on Diroximel Fumarate http://www.zacks.com/stock/news/422832/biogen-reports-interim-phase-iii-data-on-diroximel-fumarate?cid=CS-ZC-FT-422832 May 31, 2019 - Biogen (BIIB) announces new interim results from phase III EVOLVE-MS-1 study, which showed that the diroximel fumarate was generally well tolerated in people with relapsing MS.
Here are the biggest analyst calls of the day: Tesla, Apple, Citi, Verizon & more https://www.cnbc.com/2019/05/30/calls-of-the-day-tesla-apple-citi-verizon-more.html May 30, 2019 - Here are the biggest calls on Wall Street on Thursday
Jim Cramer: It's time to start buying amid market weakness, but take it slow https://www.cnbc.com/2019/05/29/jim-cramer-its-time-to-start-buying-amid-market-weakness.html May 29, 2019 - "Now that people are really freaking out ... I think it's time to start picking up stocks into weakness," Jim Cramer says.

Pages: 1...345678910111213...92

<<<Page 8>